Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Study of specific genetic and epigenetic variables in multiple myeloma.

Leukemia & lymphoma - 1 Dec 2010

Hatzimichael Eleftheria, Dasoula Aggeliki, Benetatos Leonidas, Syed Nelofer, Dranitsaris George, Crook Tim, Bourantas Konstantinos

Abstract excerpt

Few studies have examined the association between methylenetetrahydrofolate reductase (MTHFR) SNPs, epigenetic changes, and multiple myeloma (MM). We wished to determine genotype distributions for MTHFR 1298AC SNP in cases of MM and healthy controls and to examine whether there is any correlation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Case-Control Studies
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epigenesis, Genetic

Share to Genes, p16

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Multiple Myeloma

Share to Protein Serine-Threonine Kinases

Source

Identifiers

PMID: 21067440
DOI: 10.3109/10428194.2010.528095

Genes

MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21067440-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Study of specific genetic and epigenetic variables in multiple myeloma.PMID 21067440Read ↗

Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma.Semantic proximity Read ↗

Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.Semantic proximity Read ↗

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).Semantic proximity Read ↗

Tumor suppressor p16 methylation in multiple myeloma: biological and clinical implicationsSemantic proximity Read ↗

Cytotoxic T-lymphocyte antigen-4 microsatellite polymorphism is associated with multiple myeloma.Semantic proximity Read ↗

Polymorphisms contribution to the determination of significant risk of specific toxicities in multiple myeloma.Semantic proximity Read ↗

Polymorphisms involved in the folate metabolizing pathway and risk of multiple myeloma.Semantic proximity Read ↗

Inherited genetic susceptibility to multiple myeloma.Semantic proximity Read ↗

Meta-analysis of the association of MTHFR polymorphisms with multiple myeloma risk.Semantic proximity Read ↗

Promoter Hypermethylation of the MEG3 (DLK1/MEG3) Imprinted Gene in Multiple MyelomaSemantic proximity Read ↗

Detecting methylation patterns of <i>p16</i>, <i>MGMT</i>, <i>DAPK</i> and <i>E‐cadherin</i> genes in multiple myeloma patientsSemantic proximity Read ↗

CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.